OTC Markets OTCPK - Delayed Quote USD

Conavi Medical Corp. (TMDIF)

Compare
0.8175 +0.7848 (+2,400.00%)
At close: October 15 at 4:00 PM EDT
Loading Chart for TMDIF
DELL
  • Previous Close 0.0327
  • Open 0.0322
  • Bid 0.0321 x --
  • Ask 0.0400 x --
  • Day's Range 0.0322 - 0.0400
  • 52 Week Range 0.0295 - 1.0000
  • Volume 4,965
  • Avg. Volume 53,885
  • Market Cap (intraday) 93.228M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2500
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

conavi.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: TMDIF

View More

Performance Overview: TMDIF

Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TMDIF
1,240.16%
S&P/TSX Composite index
18.44%

1-Year Return

TMDIF
713.43%
S&P/TSX Composite index
26.05%

3-Year Return

TMDIF
45.50%
S&P/TSX Composite index
18.61%

5-Year Return

TMDIF
50.55%
S&P/TSX Composite index
51.11%

Compare To: TMDIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TMDIF

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    3.93M

  • Enterprise Value

    1.13M

  • Trailing P/E

    0.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.27

  • Price/Book (mrq)

    1.37

  • Enterprise Value/Revenue

    2.04

  • Enterprise Value/EBITDA

    0.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.64M

  • Net Income Avi to Common (ttm)

    -34.59M

  • Diluted EPS (ttm)

    -1.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.75M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: TMDIF

View More

Company Insights: TMDIF

Research Reports: TMDIF

View More

People Also Watch